Objectives: Currently, an increasing number of studies are focusing on the impact of m7G modification in cancer. This study aims to investigate the prognostic value of m7G-related genes in low-grade glioma (LGG).
Methods: LGG samples were obtained from the CGGA database, and normal samples were obtained from GTEx. Differentially expressed m7G-related genes were identified, and genes highly associated with macrophage M2 in LGG patients were identified by immuno-infiltration and WGCNA analysis. The intersection of differentially expressed m7G-related genes and macrophage M2-associated genes yielded candidate genes, and hub genes were identified using 5 algorithms in CytoHubba. Enrichment analysis verified the relevant pathways of hub genes, and their performance in tumor classification was evaluated.
Results: A total of 3329 differentially expressed m7G-related genes were identified. 1289 genes were highly associated with macrophage M2 in LGG patients. The intersection of m7G-related genes and results in WGCNA yielded 840 candidate genes, and six hub genes (STXBP1, CPLX1, PAB3A, APBA1, RIMS1, and GRIN2B) were identified. Hub genes were enriched in synaptic transmission-related pathways and showed good performance for tumor classification. There were significant differences in survival levels between clusters.
Conclusions: The identified m7G-related genes may provide new insight into the treatment and prognosis of LGG.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331695 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Identification of lethality-related m7G methylation modification patterns and the regulatory features of immune microenvironment in sepsis.
Heliyon
January 2025
Department of Respiratory Medicine, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Xinghualing Area, 030000, Taiyuan, China.
Objectives: N7-methylguanosine (m7G) modification is closely related to the occurrence of human diseases, but its roles in sepsis remain unclear. This study aimed to explore the patterns of lethality-related m7G regulatory factor-mediated RNA methylation modification and immune microenvironment regulatory features in sepsis.
Methods: Three sepsis-related datasets (E-MTAB-4421 and E-MTAB-4451 as training sets and GSE185263 as a validation set) were collected, and differentially expressed m7G-related genes were analyzed between survivors and non-survivors.
A novel N7-Methylguanine-related gene signature for predicting prognosis in acute myeloid leukemia: bioinformatic analysis and experimental verification.
Hematology
December 2024
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
The involvement of N7-Methylguanine (m7G) RNA methylation regulators in the progression of different types of solid cancers in humans has been established. However, the specific impact of m7G-related genes on Acute myeloid leukemia (AML) remains uncertain. Our research aims to build a novel signature of M7Gs that could enhance our understanding of the molecular heterogeneity in leukemia.
View Article and Find Full Text PDFThe 7-Methylguanosine (m7G) methylation METTL1 acts as a potential biomarker of clear cell renal cell carcinoma progression.
Transl Oncol
January 2025
Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing University, Chongqing 400030, China. Electronic address:
Article Synopsis
- * Researchers analyzed transcriptome and clinical data from The Cancer Genome Atlas, identifying 26 significant m7G-related genes, with METTL1 showing a strong correlation to ccRCC progression.
- * The findings suggest that METTL1 could be a valuable biomarker for ccRCC prognosis and may influence treatment outcomes by affecting the tumor immune environment, offering new insights for potential immunotherapy approaches.
Dynamic Profiles of Internal m7G Methylation on mRNAs in the Progression from HBV Infection to Hepatocellular Carcinoma.
Dig Dis Sci
November 2024
Department of Gastroenterology, the First Affiliated Hospital (Southwest Hospital), Army Medical University (Third Military Medical University), Gaotanyan Zhengjie 30, Shapingba District, Chongqing, 40038, China.
Article Synopsis
- This study investigates the link between internal RNA methylation (specifically m7G modification) and the development of liver cancer (HCC) caused by Hepatitis B Virus (HBV).
- Utilizing data from liver tissue samples, the researchers identified significant changes in m7G modifications across different stages of liver disease.
- Key genes (EZH2, SMARCA4, YY1) were found to be crucial in this process, indicating they could serve as potential targets for future research and cancer treatment strategies.
A novel m7G-related miRNA prognostic signature for predicting clinical outcome and immune microenvironment in colon cancer.
J Cancer
October 2024
Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Colon cancer (CC) is a highly prevalent malignancy worldwide, characterized by elevated mortality rates and poor prognosis. N7-methylguanosine (m7G) methylation is an emerging RNA modification type and involved in the development of many tumors. Despite this, the correlation between m7G-related miRNAs and CC remains to be elucidated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!